Surgery and OncologySurgery and OncologyХирургия и онкология2949-5857Publishing House ABV Press19910.17650/2220-3478-2017-7-1-11-17ORIGINAL REPORTSОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯResults of transanal mesorectumectomy in patients with rectal cancerРезультаты трансанальной мезоректумэктомии при раке прямой кишкиRasulovA. O.РасуловА. О.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478, Russia

Россия, 115478 Москва, Каширское шоссе, 23

DzhumаbaevKh. E.ДжумабаевХ. Э.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478, Russia

Россия, 115478 Москва, Каширское шоссе, 23

millennium88@mail.ruKulushevV. M.КулушевВ. М.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478, Russia

Россия, 115478 Москва, Каширское шоссе, 23

MamedliZ. Z.МамедлиЗ. З.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478, Russia

Россия, 115478 Москва, Каширское шоссе, 23

KozlovN. A.КозловН. А.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478, Russia

Россия, 115478 Москва, Каширское шоссе, 23

GordeevS. S.ГордеевС. С.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478, Russia

Россия, 115478 Москва, Каширское шоссе, 23

BaychorovA. B.БайчоровА. Б.
Russian Federation

23 Kashirskoe Shosse, Moscow 115478, Russia

Россия, 115478 Москва, Каширское шоссе, 23

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaФГБУ «Российский онкологический научный центр им. Н. Н. Блохина» Минздрава России100420177111171004201710042017Copyright ©; 2017, ABV-pressCopyright ©; 2017, АБВ-пресс2017ABV-pressАБВ-прессhttps://onco-surgery.info/jour/about/editorialPolicieshttps://onco-surgery.info/jour/article/view/199

Objective: comparative analysis of specific perioperative features and pathological characteristics of the removed sample after laparoscopic total mesorectumectomy (Lap-TME) and transanal total mesorectumectomy (Ta-TME).Materials and methods. A prospective non-randomized controlled study was carried out from November 2013 until September 2016. Patients with сТ1–4aN0–2M0 cancer of low- or medium-ampullar section of rectum were enrolled.Results. 55 and 54 patients were included in the Ta-TME and Lap-TME groups respectively. Duration of surgery was 285 min (Ta-TME group) and 260 min (Lap-TME group); median volume of blood loss was less than 100 ml; duration of hospital stay after surgery was 7 days in both groups. 1 (1.8 %) patient from Ta-TME group and 3 (5.6 %) patients from the control group had conversion to open surgery (р = 0.223). Transanal removal of the sample was done in 53.7 % of the cases in Ta-TME group and 25.5 % of the cases in Lap-TME group (p = 0.008). Complications were registered in 27,3 and 24,1 % of the patients respectively (р = 0,436). 90.9 % of the patients from Ta-TME group had Grade 2–3 quality of mesorectumectomy, while in Lap-TME group this parameter was 85.2 % (p = 0.266). Circumferential resection margin damage was observed in 7.3 % of cases from Ta-TME group and 9.3 % of cases from Lap-TME group (p = 0.488).Conclusion. Ta-TME does not worsen short-term oncological results. Further randomized studies are required to identify those patients who would benefit from bottoms up mesorectumectomy.

rectal cancertransanal mesorectumectomylaparoscopic surgerytransanal removal of the sampleрак прямой кишкитрансанальная мезоректумэктомиялапароскопическая хирургиятрансанальное извлечение препарата1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65(1):5–29. DOI: 10.3322/caac.21254.Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65(1):5–29. DOI: 10.3322/caac.21254.2. Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surg 1982;69(10):613–6. 3. Heald R.J., Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;327(8496):1479–82. PMID: 2425199.Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surg 1982;69(10):613–6. 3. Heald R.J., Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;327(8496):1479–82. PMID: 2425199.4. Wibe A., Carlsen E., Dahl O. et al. Nationwide quality assurance of rectal cancer treatment. Colorectal Dis 2006;8(3):224–9. DOI: 10.1111/j.1463-1318.2005.00924.x. PMID: 16466564.Wibe A., Carlsen E., Dahl O. et al. Nationwide quality assurance of rectal cancer treatment. Colorectal Dis 2006;8(3):224–9. DOI: 10.1111/j.1463-1318.2005.00924.x. PMID: 16466564.5. Guillou P.J., Quirke P., Thorpe H. et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365:1718–26. DOI: 10.1016/S0140-6736(05)66545-2. PMID: 15894098.Guillou P.J., Quirke P., Thorpe H. et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365:1718–26. DOI: 10.1016/S0140-6736(05)66545-2. PMID: 15894098.6. van der Pas M., Deijen C.L., Abis G.S. et al. Conversions in laparoscopic surgery for rectal cancer. Surg Endosc 2016 Oct 20. [Epub ahead of print].van der Pas M., Deijen C.L., Abis G.S. et al. Conversions in laparoscopic surgery for rectal cancer. Surg Endosc 2016 Oct 20. [Epub ahead of print].7. Targarona E.M., Balague C., Pernas J.C. et al. Can we predict immediate outcome after laparoscopic rectal surgery? Multivariate analysis of clinical, anatomic, and pathologic features after 3-dimensional reconstruction of the pelvic anatomy. Ann Surg 2008;247(4):642–9. DOI: 10.1097/SLA.0b013e3181612c6a.Targarona E.M., Balague C., Pernas J.C. et al. Can we predict immediate outcome after laparoscopic rectal surgery? Multivariate analysis of clinical, anatomic, and pathologic features after 3-dimensional reconstruction of the pelvic anatomy. Ann Surg 2008;247(4):642–9. DOI: 10.1097/SLA.0b013e3181612c6a.8. Xu W., Xu Z., Cheng H. et al. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A metaanalysis. Eur J Surg Oncol 2016;42(12):1841–50. DOI: 10.1016/j.ejso.2016.09.002.Xu W., Xu Z., Cheng H. et al. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A metaanalysis. Eur J Surg Oncol 2016;42(12):1841–50. DOI: 10.1016/j.ejso.2016.09.002.9. Martínez-Pérez A., de’Angelis N., Brunetti F. A meta-analysis comparing transanal vs. laparoscopic total mesorectal excision for rectal cancer. Eur J Surg Oncol 2016;pii: S0748-7983(16)30970-2. [Epub ahead of print]. DOI: 10.1016/j.ejso.2016.10.030.Martínez-Pérez A., de’Angelis N., Brunetti F. A meta-analysis comparing transanal vs. laparoscopic total mesorectal excision for rectal cancer. Eur J Surg Oncol 2016;pii: S0748-7983(16)30970-2. [Epub ahead of print]. DOI: 10.1016/j.ejso.2016.10.030.10. Bjørn M.X., Perdawood S.K. Transanal total mesorectal excision – a systematic review. Dan Med J 2015;62(7):pii: A5105. PMID: 26183050.Bjørn M.X., Perdawood S.K. Transanal total mesorectal excision – a systematic review. Dan Med J 2015;62(7):pii: A5105. PMID: 26183050.11. Deijen C.L., Tsai A., Koedam T.W. et al. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 2016;20(12):811–24. DOI: 10.1007/s10151-016-1545-0. PMID: 2785397.Deijen C.L., Tsai A., Koedam T.W. et al. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 2016;20(12):811–24. DOI: 10.1007/s10151-016-1545-0. PMID: 2785397.12. van der Pas M.H., Haglind E., Cuesta M.A. et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013;14 (3):210–8. DOI: 10.1016/S1470-2045(13)70016-0.van der Pas M.H., Haglind E., Cuesta M.A. et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013;14 (3):210–8. DOI: 10.1016/S1470-2045(13)70016-0.13. Fleshman J., Branda M., Sargent D.J. et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015;314(13):1346–55. DOI: 10.1001/jama.2015.10529.Fleshman J., Branda M., Sargent D.J. et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015;314(13):1346–55. DOI: 10.1001/jama.2015.10529.14. Stevenson A.R., Solomon M.J., Lumley J.W. et al. Effect of laparoscopicassisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015;314(13):1356–63. DOI: 10.1001/jama.2015.12009.Stevenson A.R., Solomon M.J., Lumley J.W. et al. Effect of laparoscopicassisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015;314(13):1356–63. DOI: 10.1001/jama.2015.12009.15. Penna M., Hompes R., Arnold S. et al. Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Ann Surg 2016 Oct 4. [Epub ahead of print].Penna M., Hompes R., Arnold S. et al. Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Ann Surg 2016 Oct 4. [Epub ahead of print].16. Staderini F., Foppa C., Minuzzo A. et al. Robotic rectal surgery: State of the art. World J Gastrointest Oncol 2016;8(11): 757–71. DOI: 10.4251/wjgo.v8.i11.757. PMID: 27895814.Staderini F., Foppa C., Minuzzo A. et al. Robotic rectal surgery: State of the art. World J Gastrointest Oncol 2016;8(11): 757–71. DOI: 10.4251/wjgo.v8.i11.757. PMID: 27895814.17. Ito M., Sugito M., Kobayashi A. et al. Relationship between multiple numbers of stapler firings during rectal division and anastomotic leakage after laparoscopic rectal resection. Int J Color Dis 2008;23(7):703–7. DOI: 10.1007/s00384-008-0470-8.Ito M., Sugito M., Kobayashi A. et al. Relationship between multiple numbers of stapler firings during rectal division and anastomotic leakage after laparoscopic rectal resection. Int J Color Dis 2008;23(7):703–7. DOI: 10.1007/s00384-008-0470-8.18. Lacy A.M., Tasende M.M., Delgado S. et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 2015;221(2):415–23. DOI: 10.1016/j.jamcollsurg.2015.03.046.Lacy A.M., Tasende M.M., Delgado S. et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 2015;221(2):415–23. DOI: 10.1016/j.jamcollsurg.2015.03.046.19. Penna M., Knol J.J., Tuynman J.B. et al. Four anastomotic techniques following transanal total mesorectal excision (TaTME). Tech Coloproctol 2016;20(3):185–91. DOI: 10.1007/s10151-015-1414-2.Penna M., Knol J.J., Tuynman J.B. et al. Four anastomotic techniques following transanal total mesorectal excision (TaTME). Tech Coloproctol 2016;20(3):185–91. DOI: 10.1007/s10151-015-1414-2.